MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.490
+0.020 (0.58%)
Apr 14, 2026, 4:00 PM EDT - Market closed
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts that cover MacroGenics stock have a consensus rating of "Buy" and an average price target of $4.60, which forecasts a 31.81% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $9.00.
Price Target: $4.60 (+31.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MacroGenics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Hold → Strong Buy Upgrades $3 → $9 | Hold → Strong Buy | Upgrades | $3 → $9 | +157.88% | Apr 10, 2026 |
| Barclays | Barclays | Buy Maintains $3 → $4 | Buy | Maintains | $3 → $4 | +14.61% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | -42.69% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | -14.04% | Sep 17, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | -14.04% | May 20, 2025 |
Financial Forecast
Revenue This Year
62.88M
from 149.50M
Decreased by -57.94%
Revenue Next Year
73.03M
from 62.88M
Increased by 16.14%
EPS This Year
-2.02
from -1.18
EPS Next Year
-1.62
from -2.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 122.4M | 94.3M | |||
| Avg | 62.9M | 73.0M | |||
| Low | 10.8M | 58.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -18.1% | 49.9% | |||
| Avg | -57.9% | 16.1% | |||
| Low | -92.8% | -6.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.05 | -1.02 | |||
| Avg | -2.02 | -1.62 | |||
| Low | -2.74 | -2.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.